Sarah Croft

15 POSTS 0 COMMENTS

Select gene single nucleotide polymorphisms found to be associated with venous...

Looking to the future, genetic testing may play a role in guiding the intensity of therapeutic interventions and preventive strategies in patients with venous...

Anticoagulants effective for pulmonary embolism resolution in hospitalised COVID-19 patients

Charles Ritchie and Young Erben
Anticoagulants alone are associated with a high rate of resolution of pulmonary embolism (PE) in patients with acute PE and COVID-19 infection. This was...

Sky Medical Technology receives FDA clearance for (W3) geko device

The Geko device
Sky Medical Technology has announced it has achieved further US Food and Drug Administration (FDA) 510(k) clearance to market the new (W3) geko device...

Biomarkers of heart failure show early reversal with catheter thrombolysis compared...

In a secondary analysis of the SUNSET sPE randomised controlled trial, Efthymios Avgerinos (University of Pittsburgh Medical Centre, Pittsburgh, USA) and colleagues found differences...

First New England enrolment into the DEXTERITY clinical trials announced

Vascular Breakthroughs and Vascular Care Connecticut have announced the first New England enrolment into the novel DEXTERITY clinical trials of local anti-inflammatory therapy to...

Venous stents remain durable following pregnancy 

pregnancy
Iliac vein stents tolerate a gravid uterus well and a possible future pregnancy should not contraindicate their usage in the treatment of pelvic venous...

Improved limb reflux prevalence and severity following iliac vein stent placement

Seshadri Raju and Michael Lucas
In patients with chronic venous disease (CVD) and associated ipsilateral limb reflux, iliac vein stenting was shown to improve the prevalence of reflux and...

SkinTE meets primary and secondary endpoints in RCT trial for venous...

PolarityTE has announced results from a multicentre randomised controlled trial (RCT) evaluating treatment of venous leg ulcers (VLUs) with its investigational product SkinTE plus...

Cardiovascular Systems partners with Innova Vascular to develop full line of...

CardioVascular Systems CSI
Cardiovascular Systems Inc (CSI) recently announced it has partnered with Innova Vascular (Innova) to develop a full line of novel thrombectomy devices.  According to a...

Systematic review deems ablation of superficial venous reflux safe for patients...

In patients with concurrent deep venous obstruction (DVO), superficial venous reflux (SVR) ablation is suggested to be safe, according to a recent systematic review....

Direct oral anti-coagulants associated with less risk of major bleeding following...

Direct oral anti-coagulants (DOACs) work just as well to prevent future clots as warfarin and are less likely to result in major bleeding after...

Blueflow venous stent for chronic iliofemoral venous disease “offers favourable primary...

Michael Lichtenberg
Deep venous stenting with the Blueflow venous stent (Plus Medica) offers favourable primary patency, and is associated with significant continued improvement of symptom severity...

NIH grant sets Mercator research underway for local anti-inflammatory DVT therapy

Mercator MedSystems has recently announced that the DEXTERITY trials research has begun under a technology transfer grant for approximately $300,000 funded by the National...

Sky Medical receives FDA clearance to market the Geko device for...

Sky Medical Technology recently announced US Food and Drug Administration (FDA) 510(k) clearance to market the Geko device for increasing microcirculatory blood flow in...

Koya Medical presents positive interim data on Dayspring lymphoedema treatment

Koya Medical recently presented data from the company’s prospective, multicentre, randomised, crossover study comparing Dayspring, the company’s active compression treatment for lymphoedema, to a...